Stanford University
Showing 5,721-5,730 of 7,777 Results
-
Fauzia Riaz, MD, MHS
Assistant Professor of Medicine (Oncology)
BioDr. Riaz is dedicated to advancing breast cancer treatment through an innovative clinical trial program that focuses on cutting-edge therapeutics and biomarkers.
Dr. Riaz is studying circulating tumor (ct)DNA-minimal residual disease (MRD) as a pivotal biomarker for early-stage breast cancer. She aims to enhance its use in surveillance and early detection while guiding personalized treatment strategies through novel clinical trials. Furthermore, she is committed to improving immunotherapy efficacy by modifying the tumor microenvironment. Her research involves developing early-phase trials that integrate novel therapeutic approaches, combining immunotherapy and radiotherapy. As a Clinical Assistant Professor at Stanford University School of Medicine, Dr. Riaz is also committed to improving the accessibility of cutting edge therapies to all patients. She is leading a collaborative effort with multiple institutions to develop databases that track patient outcomes and inform treatment practices.
Dr. Riaz’s overarching goal is to expand early-phase clinical trials and foster academic-industry partnerships to advance the field of breast oncology and improve patient care. -
Toloo Riazi
Lecturer
BioToloo Riazi joined Stanford University as Lecturer in September 2023. She completed her doctoral degree in Latin American Studies at University of California, Santa Barbara. She is specializing in contemporary Hispanic literature and culture. Her scholarly interests include revolutions, gender, migration, cultural and film studies.
-
Anthony J. Ricci, PhD
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy of Molecular and Cellular Physiology
Current Research and Scholarly InterestsWe study hearing from biophysical, molecular and signal processing perspectives. One focus is mechanotransduction, where sound is converted into an electrical signal. As a major site for dysfunction, a more detailed understand will provide a means toward intervention. We develop new antibiotics to limit ototoxicity. We investigate drug delivery methods from surgical approaches to slow release systems, including gene therapy tools. We are studying cognitive decline following hearing loss.
-
Brian Travis Rice
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsDeveloping data-driven approaches to defining and comparing chief complaints fro emergency and unscheduled acute care in low- and middle-income countries
